Faster access to cancer drugs
NICE has approved liver cancer drug, sorafenib for routine NHS use. Three-quarters of drugs covered by the cancer drugs fund (CDF) have now been approved without a negative decision. Sorafenib is eighteenth on the list of 24 drugs NICE was asked to approve for the CDF.
Sign up to receive regular news.